Answer
It targets mycobacterial energy production through ATP synthase and is licensed within combination treatment for pulmonary tuberculosis resistant to at least rifampicin and isoniazid.
Sources for this answer
- Sirturo 100 mg tabletsemc · SmPC Current selected SmPC · Version 21